Hence, the downregulation of ABR, PREX1, DOCK2, and DOCK4 promotes cancer development and leads to a poor prognosis by activating MYC and DNA repair signaling pathways in NSCLC, and further in vitro and in vivo studies are necessary to further confirm their association. The gene discussed is PREX1; the disease is non-small cell lung carcinoma.